Board
Biotica’s Board combines experience from major pharmaceutical companies, the biotechnology industry and the finance sector.
| Edward Hodgkin, D.Phil | |
| CEO and Executive Director | |
Edward Hodgkin joined Biotica as CEO in August, 2007 after 12 years in the United States. He was previously President & Chief Business Officer at San Diego-based BrainCells, Inc., a biopharmaceutical… |
|
| Mark Lampert, AB, MBA | |
| Non-Executive Director | |
Mark Lampert is the founder of BVF Partners L.P., a San Francisco-based, private investment firm established in 1994. Mr Lampert has engaged in ventures relating to the biotechnology industry since… |
|
| Peter Leadlay, PhD, FRS | |
| Non Executive Director | |
Peter Leadlay is a co-founder of Biotica and a Non-Executive Director and consultant. He is currently Herchel Smith Professor of Biochemistry at the University of Cambridge. Professor Leadlay… |
|
| Alan Lewis, PhD | |
| Non Executive Director | |
Dr Alan Lewis is the President & CEO of the Juvenile Diabetes Research Foundation. Prior to joining the JDRF in January 2009, Dr. Lewis was CEO of the San Diego biotech company, Novocell. … |
|
| Peter Ringrose, PhD | |
| Non-Executive Director | |
Dr Peter Ringrose served as Chief Scientific Officer of Bristol-Myers Squibb Company and President of the Pharmaceutical Research Institute, where he was responsible for the discovery, preclinical and… |
|
| Marc Schneidman, BA, JD | |
| Non-Executive Chairman | |
Marc Schneidman is Biotica’s Non-Executive Chairman. He joined Aquilo Partners, a life sciences investment bank, in 2009, having spent his career as an investor in the life science industry. Prior… |
|